JS Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

JS Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-170,000	Closed	-$2.33M	–	21
2016 Q3	$2.33M	Sell	170,000 -637,700	-79%	-$6.4M	0.9%	14
2016 Q2	$5.97M	Sell	807,700 -61,000	-7%	-$458K	1.15%	10
2016 Q1	$5.55M	Buy	868,700 +238,700	+38%	+$1.34M	1%	13
2015 Q4	$3.94M	Buy	630,000 +25,000	+4%	+$164K	0.94%	16
2015 Q3	$3.53M	Sell	605,000 -30,000	-5%	-$231K	0.59%	20
2015 Q2	$5.25M	Hold	635,000	–	–	1.05%	17
2015 Q1	$5.23M	Buy	635,000 +200,000	+46%	+$1.48M	1.33%	14
2014 Q4	$2.99M	Buy	435,000 +285,000	+190%	+$1.78M	0.93%	24
2014 Q3	$810K	Buy	+150,000	New	+$876K	0.13%	62

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

JS Capital Management's ARIA Position: Q4 2016 in Review

JS Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 170,000 shares — an estimated $2.33M sold.

JS Capital Management first reported a position in ARIA in Q3 2014 and held it in 9 quarters. The position peaked at $5.97M in Q2 2016. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

JS Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
JS Capital Management sold 170,000 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $2.33M.
JS Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 9 quarters.
JS Capital Management's Ariad Pharmaceuticals Inc position peaked at $5.97M in Q2 2016.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on JS Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.